Bio-Techne
TECH
#1870
Rank
A$15.97 B
Marketcap
A$102.53
Share price
-0.24%
Change (1 day)
15.36%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of March 2026 : A$0.41 Billion

According to Bio-Techne's latest financial reports the company's total debt is A$0.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-06-30A$0.67 B7.39%
2024-06-30A$0.62 B-7.92%
2023-06-30A$0.68 B44.46%
2022-06-30A$0.47 B-15.75%
2021-06-30A$0.56 B-10.7%
2020-06-30A$0.62 B-12.67%
2019-06-30A$0.71 B57.07%
2018-06-30A$0.45 B2.27%
2017-06-30A$0.44 B250.12%
2016-06-30A$0.12 B27.75%
2015-06-30A$0.10 B629.16%
2014-06-30A$13.72 M
2006-06-30A$18.15 M-5.23%
2005-06-30A$19.15 M-16.57%
2004-06-30A$22.95 M-10.26%
2003-06-30A$25.58 M-20.44%
2002-06-30A$32.15 M-13.09%
2001-06-30A$37 M12.54%
2000-06-30A$32.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
A$61.80 B 14,766.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$24.74 B 5,851.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$27.43 B 6,498.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$26.46 B 6,266.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.35 B 467.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
A$4.3 M-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$1.97 B 374.71%๐Ÿ‡บ๐Ÿ‡ธ USA